T 1515/20 (Inhibitor of complement / ALEXION PHARMACEUTICALS) of 21.09.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T151520.20230921
- Date of decision
- 21 September 2023
- Case number
- T 1515/20
- Petition for review of
- -
- Application number
- 16195355.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 R 139
- Application title
- Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
- Applicant name
- Alexion Pharmaceuticals, Inc.
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 76(1)European Patent Convention Art 83European Patent Convention R 139Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Added subject-matter (yes) - main request and auxiliary request 4
Admittance (no) - auxiliary requests 1 to 3
Added subject-matter (no), sufficency, novelty inventive step (yes) - auxiliary request 5 - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division with the order to grant a patent in the following form:
- Description:
pages 1 to 55 as filed;
- Claims:
No 1 and 2 of auxiliary request 5 filed with the statement of grounds of appeal;
- Drawings:
sheets 1/4 to 4/4 as filed;
- Sequence listings:
SEQ ID No: 1 to 10 as filed.